trigram

This is a table of type trigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

trigram	frequency
background case studies	481
study design method	387
the use of	318
as well as	314
or case report	241
purpose or case	241
the development of	217
the united states	216
the number of	199
in order to	194
food and drug	187
and drug administration	182
one of the	168
in patients with	167
the treatment of	159
in addition to	151
the risk of	149
in the united	149
due to the	140
study design methods	138
the presence of	132
a total of	128
based on the	118
to determine the	105
the need for	98
red blood cells	97
the purpose of	96
there is a	93
such as the	90
for the treatment	89
a variety of	85
the detection of	84
guidance for industry	84
of this study	84
red blood cell	81
the implementation of	80
a number of	79
the blood bank	79
the most common	78
by the fda	75
in the treatment	74
some of the	73
be used to	72
purpose of this	71
was used to	71
in this study	70
the majority of	67
according to the	67
the ability to	66
to evaluate the	66
for the detection	66
there was no	65
of patients with	65
need to be	65
study was to	64
the evaluation of	64
compared to the	64
it is important	64
this study was	64
may not be	63
part of the	63
as a result	63
use of the	63
review of the	62
role in the	62
for use in	62
evaluation of the	62
at our institution	61
use of a	61
used in the	61
can be used	61
it has been	61
at the time	60
implementation of the	59
the time of	59
used to treat	58
the role of	58
in the us	57
related to the	57
is important to	57
in the pediatric	57
to reduce the	56
the us fda	56
were used to	55
the impact of	55
acute respiratory syndrome	54
severe acute respiratory	54
to assess the	53
of the disease	52
the effect of	52
of the product	52
the safety of	52
and safety of	52
the case of	51
addition to the	51
safety and efficacy	51
the lack of	51
to ensure that	51
associated with the	51
the identification of	51
as part of	51
the quality of	51
the potential to	51
the efficacy of	50
the food and	50
the steering committee	50
of the most	50
the diagnosis of	49
in response to	49
has not been	49
the objective of	49
the importance of	49
have been reported	48
fda approved drugs	48
depending on the	47
the level of	47
that can be	47
in the case	47
can lead to	46
center background case	46
a history of	46
development of a	46
found to be	46
the harmonization of	45
included in the	45
the incidence of	45
the absence of	45
the aim of	45
there is no	45
the university of	45
have been developed	45
most of the	44
over the past	44
years of age	44
fda labels for	44
well as the	44
the establishment of	43
a review of	43
the production of	43
there was a	43
it is a	43
each of the	43
because of the	42
involved in the	42
in the development	42
that have been	42
hepatitis c virus	42
been shown to	42
prior to the	42
for patients with	42
a and b	41
the potential for	41
the creation of	41
the need to	41
of a new	41
the fact that	41
has also been	41
efficacy and safety	41
was performed using	40
be able to	40
is one of	40
in of patients	40
before and after	40
in combination with	39
the results of	39
have also been	39
the human genome	39
world health organization	39
the safety and	39
resulted in a	39
of the virus	39
of the eu	39
objective of this	39
the end of	39
understanding of the	39
is responsible for	39
an average of	38
approved by the	38
in which the	38
mechanism of action	38
at least one	38
is associated with	38
has been reported	38
of the patients	38
the patient was	38
used for the	38
in the eu	38
associated with a	38
in the setting	37
wide range of	37
the development and	37
was found to	37
to determine if	37
harmonization of pharmaceutical	37
head and neck	37
a patient with	37
some of these	36
is the most	36
the setting of	36
disinfection and sterilization	36
the management of	36
the effectiveness of	36
there were no	36
of the first	35
as compared to	35
the goal of	35
for treatment of	35
of blood products	35
ich steering committee	35
a wide range	35
of the ich	35
and efficacy of	35
was associated with	35
exchange of information	35
was performed by	34
of the drug	34
the frequency of	34
the amount of	34
the possibility of	34
is based on	34
for detection of	34
weak d type	34
were reported in	34
the ich steering	34
respiratory syndrome coronavirus	34
of the new	34
the pediatric population	34
by the food	34
be used for	34
it is not	34
based on a	34
hematopoietic stem cell	34
in the literature	34
has indicated that	34
in the blood	33
united states food	33
for disease control	33
is used to	33
development of the	33
in the region	33
increase in the	33
the prevalence of	33
of health and	32
it is also	32
the availability of	32
retrospective review of	32
the transfusion service	32
magnetic resonance imaging	32
to ensure the	32
in the past	32
states food and	32
to improve the	32
of the european	32
study is to	32
in terms of	32
human immunodeficiency virus	32
influenza a h	32
the fda has	32
in the future	32
sickle cell disease	32
a result of	31
in vitro and	31
this study is	31
and in the	31
in a patient	31
the ability of	31
control and prevention	31
the basis of	31
the context of	31
and the us	31
of the pediatric	31
the performance of	31
to be a	31
to support the	31
should not be	31
this is a	31
an increase in	31
in the presence	31
centers for disease	31
for evaluation of	31
congenital heart disease	31
there are no	31
health and human	30
of the study	30
due to its	30
of clinical trials	30
disease control and	30
research and development	30
the past years	30
in pediatric patients	30
used as a	30
of the blood	29
use of antibiotics	29
end of the	29
analysis of the	29
an important role	29
of blood components	29
classified by the	29
important role in	29
for the development	29
american red cross	29
at the same	29
was performed to	29
european medicines agency	29
in accordance with	29
the discovery of	29
the member states	29
all of the	29
has been shown	29
to facilitate the	29
and human services	29
a medical device	29
of pharmaceutical regulations	29
increased risk of	29
to provide a	29
to have a	29
due to a	29
with respect to	29
morbidity and mortality	29
the european medicines	29
of a medical	29
response to the	29
department of health	28
to be the	28
use in the	28
in the educational	28
for up to	28
in the context	28
in children with	28
discuss or describe	28
was determined by	28
for the evaluation	28
the public health	28
to the fda	28
been reported in	28
the world health	28
on the other	28
and can be	28
sensitivity and specificity	28
public health emergency	28
imaging findings of	28
will discuss or	28
the effects of	28
a retrospective review	28
medical device or	28
a case of	28
shown to be	28
a series of	28
a range of	28
safe and effective	28
polymerase chain reaction	27
members of the	27
the course of	27
has the potential	27
vitro and in	27
has been used	27
reduce the risk	27
pharmaceutical that is	27
investigational for intended	27
american college of	27
a use of	27
in the usa	27
of the test	27
the same time	27
that is classified	27
aim of this	27
emergency use authorization	27
should be considered	27
of these patients	27
in the first	27
the educational content	27
is classified by	27
for intended use	27
of the human	27
was performed on	27
have shown that	27
and implementation of	27
the percentage of	27
device or pharmaceutical	27
or pharmaceutical that	27
in the absence	27
of the patient	27
as investigational for	27
blood and blood	26
were observed in	26
the introduction of	26
in the s	26
to note that	26
could not be	26
up to days	26
the age of	26
to identify the	26
likely to be	26
the department of	25
with the use	25
the rate of	25
of the donor	25
found in the	25
of fda approved	25
for human use	25
on the basis	25
obtained from the	25
the other hand	25
the formation of	25
to determine whether	25
have not been	25
dependent rna polymerase	25
with regard to	25
and development of	25
may also be	25
to investigate the	25
when compared to	25
will be presented	25
a transfusion vol	25
significant difference in	25
this is the	25
treatment of covid	25
electronic medical record	25
kcal mol and	25
should also be	25
were found to	25
be associated with	25
have been used	25
in the same	25
none of the	25
do not have	25
that may be	24
knowledge of the	24
the assessment of	24
no significant differences	24
middle east respiratory	24
to develop a	24
was observed in	24
in the study	24
to the development	24
differences in the	24
a reduction in	24
can also be	24
of a single	24
information on the	24
testing was performed	24
and management of	24
east respiratory syndrome	24
any of the	24
of the pharmaceutical	24
docking score of	24
in both the	24
during the first	24
in the evaluation	24
of the clinical	24
west nile virus	24
section of the	24
in recent years	24
patients with a	24
are based on	24
type and screen	24
clinical trials in	24
in the number	24
were performed on	24
antibiotic use in	24
hepatitis b virus	24
has led to	23
the spectrum of	23
total number of	23
school of medicine	23
in the pharmaceutical	23
the product is	23
medical center background	23
added to the	23
of public health	23
and use of	23
observed in the	23
will also be	23
of blood donors	23
reported in the	23
the animal rule	23
of red blood	23
in a large	23
patient blood management	23
assessment of the	23
studies have shown	23
in the clinical	23
of medicinal products	23
of the current	23
a combination of	23
is critical to	23
in this case	22
is necessary to	22
in clinical trials	22
exhibit is to	22
standard of care	22
and in vivo	22
half of the	22
and of the	22
more likely to	22
to demonstrate the	22
and public health	22
the fda and	22
the field of	22
is needed to	22
the ema and	22
in some cases	22
the adoption of	22
a systematic review	22
responsible for the	22
are needed to	22
was to evaluate	22
assessment report of	22
was performed in	22
after the first	22
assisted laser desorption	22
over the years	22
the exchange of	22
to create a	22
the type of	22
that there is	21
and for the	21
will be discussed	21
it is the	21
difference between the	21
important to note	21
is the first	21
a lack of	21
was defined as	21
found to have	21
for the first	21
with a history	21
in a single	21
there has been	21
to review the	21
intensive care unit	21
needs to be	21
implementation of a	21
led to a	21
us food and	21
the ich regions	21
performance of the	21
in relation to	21
impact on the	21
a docking score	21
in the world	21
member of the	21
caused by the	21
reported to be	21
the expression of	21
used to determine	21
the levels of	21
development of new	21
been reported to	21
the blood center	21
led to the	21
safety of the	21
was used for	21
weak d types	21
the scope of	21
ligand efficiency of	21
the most important	21
analysis was performed	20
respiratory syncytial virus	20
the extent of	20
in this regard	20
and harmonization of	20
to address the	20
the european union	20
at the university	20
was reported in	20
in the field	20
and treatment of	20
laser desorption ionization	20
be used as	20
herpes simplex virus	20
the fda to	20
to the blood	20
in a study	20
massive transfusion protocol	20
has been a	20
patients who received	20
central nervous system	20
in the diagnosis	20
the process of	20
a group of	20
the area of	20
in cases of	20
the addition of	20
a h n	20
the mechanism of	20
with or without	20
the most commonly	20
many of these	20
the us and	20
for the diagnosis	20
as a potential	20
the study period	20
interstitial lung disease	20
in the early	20
one or more	20
in conjunction with	20
more than one	20
along with the	20
a clinical trial	19
which may be	19
by flow cytometry	19
of the assay	19
in the ema	19
patients with severe	19
cd t cells	19
at risk of	19
did not have	19
for identification of	19
the fda in	19
there is an	19
is an important	19
the value of	19
of whole blood	19
the prevention of	19
in the u	19
of ebola virus	19
each of these	19
were able to	19
the american college	19
to detect the	19
at risk for	19
patients treated with	19
one of these	19
many of the	19
supported by the	19
high levels of	19
of antibiotics in	19
provided by the	19
indicated that he	19
between the two	19
the application of	19
determined to be	19
been used to	19
was seen in	19
the difference between	19
identified in the	19
should be used	19
to compare the	19
it is possible	19
in contrast to	19
therapeutic plasma exchange	19
part of a	19
at the end	19
continue to be	19
of which were	19
blood center background	19
of the viral	19
the duration of	19
change in the	19
which has been	19
the study was	19
blood and marrow	19
could be used	19
better understanding of	19
structure of the	19
within hours of	19
present in the	19
to be used	19
in the event	19
there have been	19
a list of	19
an overview of	19
it may be	19
were obtained from	18
the sensitivity of	18
are associated with	18
ema assessment report	18
the nature of	18
the basis for	18
code of federal	18
may lead to	18
and identification of	18
the donor is	18
flight mass spectrometry	18
stem cell transplantation	18
the activity of	18
effectiveness of the	18
be due to	18
continues to be	18
regions of the	18
case of a	18
it should be	18
impact of the	18
medicinal products for	18
peripheral blood stem	18
been associated with	18
significant differences in	18
the blood supply	18
the increase in	18
be used in	18
resulted in the	18
to establish the	18
an effort to	18
we present a	18
of the system	18
of the american	18
up to of	18
with an average	18
is used in	18
the pharmaceutical industry	18
at this time	18
pediatric patients with	18
in most cases	18
in the post	18
a set of	18
pre and post	18
were included in	18
whether or not	18
large number of	18
ebola virus disease	18
in all cases	18
of the federal	18
fd c act	18
disease of the	18
the benefits of	18
of federal regulations	18
risk factors for	18
is known to	18
the risks of	18
the ema assessment	18
the severity of	18
of more than	18
is a rare	18
stored for days	18
have the potential	18
a summary of	18
not associated with	17
a diagnosis of	17
difference in the	17
was able to	17
diseases such as	17
use in food	17
it is critical	17
which is a	17
the centers for	17
all of these	17
the cost of	17
presence of a	17
and lack of	17
regional blood center	17
canadian blood services	17
lead to a	17
the patient and	17
appear to be	17
of transmission of	17
of the major	17
and should be	17
was to determine	17
and the fda	17
diagnosis and treatment	17
will continue to	17
also known as	17
this educational exhibit	17
the accuracy of	17
treatment of patients	17
number of units	17
is required to	17
the electronic medical	17
broad range of	17
in the last	17
with a docking	17
compared with the	17
the review of	17
revealed that the	17
a role in	17
used to assess	17
in animal feed	17
the american society	17
are required to	17
evaluation of a	17
a public health	17
have been shown	17
clinical trials for	17
considered to be	17
a decrease in	17
in comparison to	17
is a major	17
the emergence of	17
were associated with	17
were tested for	17
that do not	17
in the area	17
investigational new drug	17
the total number	17
of the time	17
quality and safety	17
no significant difference	17
and cosmetic act	17
months of age	17
of red cell	17
a large number	17
suggest that the	17
the last years	17
hospital background case	17
limit of detection	17
quality of the	17
the vitek ms	17
that of the	16
fda and the	16
at the national	16
size of the	16
of these cases	16
signs and symptoms	16
mol and ligand	16
to describe the	16
a spectrum of	16
the active site	16
the degree of	16
approved for use	16
the ich process	16
fresh frozen plasma	16
approximately of the	16
by the ema	16
the immune system	16
over the last	16
outside of the	16
the fd c	16
submitted to the	16
and ligand efficiency	16
the united kingdom	16
to our knowledge	16
of influenza a	16
donors in the	16
in vitro quality	16
to study the	16
around the world	16
and it is	16
by the manufacturer	16
risks associated with	16
has resulted in	16
establishment of the	16
high risk of	16
study of the	16
for use of	16
in public health	16
the face of	16
of the sars	16
in transfusion medicine	16
will be used	16
american society for	16
has been developed	16
critically ill patients	16
known to be	16
from the fda	16
to be an	16
in the following	16
appearance of the	16
data on the	16
ct and mri	16
was the first	16
as an important	16
of pediatric radiology	16
was designed to	16
to the current	16
of the world	16
of medically important	16
out of the	16
information about the	16
a broad range	16
a member of	16
in both groups	16
implementation of this	16
virus infection in	16
good manufacturing practice	16
based on this	16
for the prevention	16
establishment of a	16
majority of the	16
well as to	16
is a common	16
number of patients	16
the regulation of	16
the size of	16
a change in	16
were evaluated for	16
were found in	16
may be a	16
the phs act	16
seasonal influenza a	15
of action of	15
in this area	15
the image gently	15
with a high	15
are involved in	15
of the potential	15
academic medical center	15
of transfusion medicine	15
the european commission	15
at high risk	15
a dose of	15
for the use	15
of patients who	15
the result of	15
with and without	15
was created to	15
to develop and	15
of the vaccine	15
public health and	15
we report a	15
hemolytic transfusion reactions	15
ema and the	15
small number of	15
from the same	15
by the american	15
the vast majority	15
in the production	15
national medical center	15
and the ema	15
goal of this	15
the feasibility of	15
in health care	15
patients with covid	15
that he will	15
of the fetus	15
to provide an	15
samples were tested	15
the existence of	15
that has been	15
of the fda	15
associated with increased	15
used to evaluate	15
a wide variety	15
whole blood and	15
the efficacy and	15
that are not	15
creation of the	15
to meet the	15
it is an	15
to be performed	15
a year old	15
comparison of the	15
and control of	15
may be used	15
time of flight	15
of the national	15
the diagnosis and	15
assay for the	15
cancer drug manual	15
chronic hepatitis c	15
what is the	15
donors should be	15
the success of	15
used as an	15
are likely to	15
health care professionals	15
wide variety of	15
is essential to	15
were divided into	15
the federal food	15
consistent with the	15
has been the	15
is not a	15
at room temperature	15
determine if the	15
found that the	15
nature of the	15
are used to	15
in a timely	15
in the face	15
and may be	15
for at least	15
safety and effectiveness	15
the results were	15
the centralized procedure	15
ranged from to	15
needed to be	15
as long as	15
hemolytic disease of	15
growth factor receptor	14
that they have	14
at a large	14
products for human	14
in all patients	14
throughout the world	14
were used for	14
a panel of	14
for assessment of	14
the likelihood of	14
the status of	14
for blood and	14
imaging of the	14
public health emergencies	14
from whole blood	14
the spread of	14
significant impact on	14
more than of	14
that could be	14
of the common	14
is characterized by	14
the fda approved	14
safety evaluation of	14
ensure that the	14
that it is	14
of the three	14
is also a	14
of novel coronavirus	14
of children with	14
at increased risk	14
performed on the	14
the conduct of	14
of the asean	14
in the table	14
been used for	14
in the plasma	14
identification of the	14
an opportunity to	14
ease of use	14
this type of	14
be performed on	14
test for the	14
in the management	14
for the future	14
is difficult to	14
o neg rbc	14
of infectious diseases	14
a better understanding	14
of a variety	14
infections associated with	14
of antibiotic resistance	14
acute myeloid leukemia	14
of the development	14
of the cases	14
the time to	14
yet to be	14
period of time	14
were treated with	14
the utility of	14
step in the	14
effect on the	14
were collected from	14
was evaluated using	14
are shown in	14
the present study	14
he will discuss	14
adverse event reporting	14
health care facilities	14
current good manufacturing	14
changes in the	14
of pharmaceutical products	14
described in the	14
resulting in a	14
creation of a	14
of adverse events	14
age of the	14
the proportion of	14
the control of	14
and blood components	14
of patients and	14
solid organ transplant	14
testing of the	14
on the market	14
university school of	14
and the other	14
of zika virus	14
of the region	14
access to the	14
the clinical laboratory	14
studies should be	14
to measure the	14
the alinity s	14
the day of	14
showed that the	14
for the identification	14
been used in	14
vast majority of	14
of the same	14
patient information leaflet	14
of the donors	14
to make a	14
not limited to	14
the surface of	14
in collaboration with	14
play a role	14
the manufacturing process	14
to be able	14
the first time	14
blood stem cell	14
is essential for	14
were reported to	14
high degree of	14
appears to be	14
the imaging findings	14
defined as the	14
a period of	14
participate in the	14
were compared to	13
guidelines for the	13
and specificity of	13
a lot of	13
in the european	13
supplementary figure s	13
findings of the	13
may result in	13
drug supply chain	13
national and international	13
of the ctd	13
that the patient	13
the transfusion medicine	13
was evaluated on	13
it can be	13
hiv and hcv	13
as a consequence	13
study was performed	13
in a recent	13
was reported to	13
a tertiary care	13
a single market	13
flexible gastrointestinal endoscopes	13
technical requirements for	13
which can be	13
well as a	13
was performed with	13
all member states	13
to allow for	13
the immune response	13
in spite of	13
are present in	13
seems to be	13
of information and	13
report of the	13
of the gcc	13
for the clinical	13
in the fda	13
moderate to severe	13
is to review	13
for more than	13
expression of the	13
for each of	13
in an effort	13
indicated that she	13
blood bank and	13
portion of the	13
summary of the	13
the relationship between	13
such as a	13
the administration of	13
plays an important	13
several studies have	13
on the day	13
results of the	13
were subjected to	13
of the endoscope	13
be useful in	13
the comparator assay	13
was significantly higher	13
ranging from to	13
performed on a	13
of a novel	13
to play a	13
for clinical use	13
developed by the	13
mild to moderate	13
on day and	13
of these lesions	13
of information on	13
objective was to	13
patients who had	13
of the products	13
of this educational	13
for which the	13
of the us	13
was approved by	13
thought to be	13
for medicinal products	13
by the us	13
the event of	13
were performed in	13
the fda for	13
were detected in	13
intended for use	13
could lead to	13
to enhance the	13
in which a	13
course of the	13
well as in	13
average number of	13
but it is	13
are the most	13
was created in	13
to have an	13
ebola virus infection	13
the patient is	13
so that the	13
specificity of the	13
during the study	13
with the fda	13
the gold standard	13
in the process	13
bacterial contamination of	13
the most frequent	13
to prevent the	13
with the exception	13
clinically significant antibodies	13
we performed a	13
compared to other	13
of the vector	13
the beginning of	13
shown in table	13
efficacy of the	13
likely due to	13
that she will	13
samples were collected	13
the patient had	13
rbcs stored for	13
for the presence	13
the clinical trial	13
she will discuss	13
us fda and	13
when there is	13
route of administration	13
located in the	13
is designed to	13
be necessary to	13
is important for	13
phase i ii	13
there are a	13
be given to	13
clinical trials are	13
sterile drug products	13
in these patients	13
use of these	13
performed in the	13
and exchange of	13
and there is	13
it would be	12
were identified in	12
draft guidance for	12
hemolytic transfusion reaction	12
of viral load	12
patients in the	12
cooperation and harmonization	12
a compounding pharmacy	12
the early s	12
as soon as	12
more effective than	12
not appear to	12
will need to	12
bone marrow transplantation	12
to the patient	12
lead to the	12
the method of	12
a critical role	12
to test the	12
detection of respiratory	12
has been made	12
for infectious disease	12
the differential diagnosis	12
for the rapid	12
to confirm the	12
day and day	12
of our study	12
in whole blood	12
stem cell transplant	12
for pediatric radiology	12
seen in the	12
gene therapy products	12
with sickle cell	12
the future of	12
the exception of	12
and assessment of	12
in the vaccine	12
and to the	12
image gently campaign	12
genotyping was performed	12
to be tested	12
high risk for	12
the national dras	12
the advent of	12
limited number of	12
of the phs	12
as one of	12
the drug was	12
was found in	12
with the same	12
of these products	12
even if the	12
were performed with	12
addition to these	12
in patients receiving	12
binds to the	12
rna dependent rna	12
clinical evaluation of	12
results indicate that	12
prior to transfusion	12
data from the	12
an analysis of	12
and it was	12
can be a	12
emerging infectious diseases	12
for hiv and	12
order to ensure	12
and clinical trials	12
h n influenza	12
use of blood	12
were compared with	12
the combination of	12
by use of	12
of technical requirements	12
the pediatric patient	12
in of cases	12
have been described	12
of the total	12
overview of the	12
to estimate the	12
significantly higher in	12
of the who	12
direct antiglobulin test	12
evaluation and research	12
risk of transmission	12
by the blood	12
the cause of	12
content and format	12
results showed that	12
available on the	12
blood donor center	12
is to provide	12
to the use	12
that would be	12
in of the	12
to illustrate the	12
as it is	12
european pharmaceutical system	12
is involved in	12
the transmission of	12
and the united	12
imaging findings in	12
contribute to the	12
global public health	12
were positive for	12
interpretation of the	12
study was conducted	12
cell lung cancer	12
the interpretation of	12
no evidence of	12
or absence of	12
of severe acute	12
of the procedure	12
not be used	12
imaging features of	12
as opposed to	12
to be associated	12
because it is	12
may have a	12
are required for	12
college of medicine	12
may be more	12
in the public	12
there may be	12
we found that	12
followed by a	12
to the us	12
in the assessment	12
the care of	12
systematic review of	12
and quality of	12
bmsc and amsc	12
will not be	12
between the us	12
evaluation of pediatric	12
of up to	12
be noted that	12
a pictorial review	12
have been approved	12
was isolated from	12
the eu and	12
are included in	12
be performed in	12
is important in	12
results suggest that	12
clinical trials and	12
detected in the	12
steering committee meeting	12
the european parliament	12
blood group system	12
can be found	12
the us food	12
was no significant	12
disease in the	12
a high degree	12
are summarized in	12
harmonization of standards	12
that did not	12
the association between	12
to minimize the	12
may be useful	12
united states and	12
the occurrence of	12
is expected to	12
more than a	12
the study of	12
studies were performed	12
summarized in table	12
of these drugs	12
margin of safety	12
eu member states	12
binding to the	12
at a tertiary	12
to monitor the	12
the inhibition of	12
to screen and	12
were correlated with	12
and compared to	12
to occur in	12
tests that are	12
were reviewed for	12
cleaning and disinfection	12
countries in the	12
be aware of	12
can result in	12
in food animals	12
reported in of	12
presence of the	11
from january to	11
they can be	11
to establish a	11
during the covid	11
was less than	11
is used for	11
result of a	11
can be identified	11
performance of a	11
in many cases	11
of participants receiving	11
be considered when	11
indicate that the	11
in the liver	11
will be described	11
for clinical trials	11
college of radiology	11
have been identified	11
of the member	11
the collection of	11
used to identify	11
to public health	11
be considered in	11
mouse model of	11
the decision to	11
under the animal	11
is defined as	11
recommended by the	11
of the sadc	11
a way to	11
the european pharmaceutical	11
epidermal growth factor	11
the change in	11
has been very	11
but did not	11
to years of	11
a recent study	11
statistically significant difference	11
been developed to	11
this can be	11
important in the	11
university medical center	11
in the form	11
are subject to	11
bpa and bpn	11
affected by the	11
of the various	11
were tested with	11
were analyzed for	11
have led to	11
clinical and laboratory	11
need for a	11
duration of the	11
be the most	11
in the animal	11
one patient had	11
quality control of	11
human genome project	11
increases the risk	11
of at least	11
of human immunodeficiency	11
and effectiveness of	11
was the most	11
the bact alert	11
the samples were	11
patients with scd	11
not yet been	11
member states and	11
medicines in the	11
to rbcs stored	11
to see if	11
should be performed	11
vitamin d deficiency	11
would be a	11
to participate in	11
are necessary to	11
to patients with	11
that resulted in	11
by a single	11
of blood transfusion	11
was determined to	11
as high as	11
approved drugs against	11
has been established	11
component of the	11
and maintenance of	11
patient safety and	11
the clinical trials	11
the standard of	11
activity of the	11
the european community	11
may have been	11
a subset of	11
is a relatively	11
cov m pro	11
presence or absence	11
new automated alinity	11
taking into account	11
for the management	11
the objectives of	11
c and e	11
in pag c	11
administration of the	11
referred to as	11
of the other	11
the limit of	11
to be more	11
most of these	11
we were able	11
drug discovery and	11
due to their	11
to treat covid	11
test was used	11
blood donors with	11
use of an	11
the association of	11
resistant staphylococcus aureus	11
the protection of	11
from patients with	11
significant increase in	11
for use on	11
the system and	11
can be performed	11
similar to the	11
basis of the	11
was identified in	11
to examine the	11
the eu has	11
the disease and	11
reported to occur	11
information in the	11
national institute of	11
more than million	11
removed from the	11
serves as a	11
is due to	11
such as those	11
is critical for	11
performed to determine	11
the distribution of	11
of this exhibit	11
also be discussed	11
in the late	11
there should be	11
of a drug	11
to the united	11
of these studies	11
of the literature	11
focus on the	11
there is little	11
an important step	11
fast brain mri	11
it was agreed	11
the clinical and	11
time quantitative pcr	11
was not statistically	11
for the patient	11
drugs and biologics	11
the needs of	11
version of the	11
and distribution of	11
the pediatric spine	11
for diagnosis of	11
known as the	11
the fetus and	11
immune response to	11
review of all	11
surface of the	11
that will be	11
the preparation of	11
of the process	11
on how to	11
patients infected with	11
critical in the	11
with weak d	11
the form of	11
used as the	11
goal was to	11
information and patient	11
by comparing the	11
a case report	11
risk of adverse	11
allows for the	11
between member states	11
antibiotics in animal	11
are not available	11
of the samples	11
are at risk	11
two of the	11
have to be	11
donors with a	11
the design of	11
we reviewed the	11
quality of medicines	11
the analysis of	11
public health service	11
with the goal	11
national institutes of	11
response to a	11
of hepatitis b	11
against the virus	11
endoscopic retrograde cholangiopancreatography	11
rt on day	11
which is the	11
of all the	11
focused on the	11
taken into consideration	11
effect of the	11
to implement the	11
an outbreak of	11
automated alinity s	11
critical role in	11
was referred to	11
harmonization and cooperation	11
aim of the	11
patients with chronic	11
this exhibit is	11
and the blood	11
and has been	11
the patients with	11
on the development	11
are known to	11
mmol g hb	11
were evaluated by	11
issues related to	11
of the best	11
available in the	11
implementation of ich	10
characterization of the	10
in the brain	10
anatomy of the	10
was not associated	10
there are also	10
a limited number	10
hld or sterilization	10
which there is	10
may be due	10
the onset of	10
higher than the	10
age and sex	10
a pivotal role	10
all patients with	10
of medical products	10
pictorial review of	10
to the fact	10
products in the	10
and is used	10
the first step	10
regardless of the	10
of the brain	10
they should be	10
for the production	10
is required for	10
in the patient	10
sent to the	10
from the national	10
based on their	10
for the following	10
there are many	10
parts of the	10
of flight mass	10
as much as	10
antibodies in the	10
in the near	10
the content of	10
of the harmonization	10
trade and investment	10
in the host	10
society of gastroenterology	10
bone marrow transplant	10
good manufacturing practices	10
approach to identify	10
were reviewed by	10
the type and	10
has been applied	10
have been a	10
has been an	10
were used as	10
characteristics of the	10
is also important	10
there are several	10
society for pediatric	10
nucleic acid testing	10
and blood products	10
were more likely	10
were transfused with	10
and with the	10
by reducing the	10
broad spectrum of	10
status of the	10
during the development	10
it is imperative	10
for use by	10
were prepared from	10
nucleic acid amplification	10
us and mri	10
cov and sars	10
to promote the	10
the national level	10
and the use	10
the animal model	10
small cell lung	10
of the above	10
be applied to	10
needed to support	10
in patient care	10
blood donor screening	10
is a human	10
was shown to	10
types of products	10
used to compare	10
to decrease the	10
a timely manner	10
data was collected	10
of infectious disease	10
the search for	10
and after the	10
contact with the	10
will be able	10
it is clear	10
gold standard for	10
and the development	10
of american pathologists	10
is possible that	10
and the need	10
the types of	10
was obtained from	10
are designed to	10
tested on the	10
form of the	10
for the purpose	10
neonatal intensive care	10
the selection of	10
in a clinical	10
educational exhibit is	10
determine the optimal	10
for both the	10
cd cells ml	10
involvement of the	10
on the surface	10
the structure of	10
id rhd xt	10
the antibody screen	10
is critical in	10
of drug development	10
platelet additive solution	10
it was also	10
then used to	10
which can lead	10
validation of the	10
in the year	10
will focus on	10
the pharmaceutical sector	10
from the blood	10
it is worth	10
not significantly different	10
at that time	10
in vitro studies	10
a and c	10
rapid detection of	10
and hydrophobic interactions	10
angiotensin receptor blockers	10
top of the	10
been developed for	10
american association of	10
method for the	10
the in vitro	10
a commercially available	10
college of american	10
our ability to	10
health care providers	10
a function of	10
aid in the	10
been linked to	10
university of michigan	10
c virus infection	10
is a useful	10
published in the	10
of health care	10
of the transfusion	10
be taken into	10
play an important	10
weak d phenotype	10
the initiation of	10
different types of	10
the h n	10
norms and standards	10
of respiratory viruses	10
institutional review board	10
were observed for	10
at the blood	10
hepatitis b surface	10
the practice of	10
occur in the	10
certain types of	10
compared to those	10
be required to	10
length of stay	10
if the donor	10
a prospective study	10
sequencing of the	10
no statistically significant	10
in line with	10
we sought to	10
was sent to	10
leading to a	10
speci fi c	10
the visionv r	10
not have a	10
and evaluation of	10
will review the	10
are intended to	10
was no difference	10
have been made	10
on behalf of	10
report a case	10
can be easily	10
the weak d	10
are able to	10
goal is to	10
risk of infection	10
it does not	10
fda approved drug	10
packed red blood	10
blood donors were	10
both of these	10
to increase the	10
medicine background case	10
american society of	10
of the following	10
the scientific community	10
cooperation in the	10
their ability to	10
sensitivity was evaluated	10
the average number	10
university of washington	10
that the fda	10
acute lung injury	10
hbv and hcv	10
is to demonstrate	10
in recognition of	10
respiratory tract infections	10
the final product	10
cobasv r zika	10
and interpretation of	10
different stages of	10
no difference in	10
phase iii trial	10
results in a	10
to achieve the	10
effective use of	10
the quality and	10
the fda is	10
if it is	10
available for the	10
an alternative to	10
were stored at	10
of gene therapy	10
university of california	10
is not always	10
hydroxychloroquine and chloroquine	10
were no significant	10
key role in	10
in children and	10
the rhd gene	10
use of medically	10
the valid act	10
of the genome	10
linked to the	10
because of its	10
the host cell	10
of the protein	10
human papilloma virus	10
components of the	10
region of the	10
our blood center	10
monitoring of the	10
the secretary of	10
recognition of the	10
with a new	10
point of care	10
introduced in the	10
systematic review and	10
to donate blood	10
the goals of	10
and so on	10
red cross blood	10
rapid diagnosis of	10
we will review	10
the time the	10
the causative agent	10
the choice of	10
the benefit of	10
of the population	10
be found in	10
this exhibit will	10
adverse events were	10
viral replication and	10
for infectious diseases	10
is supported by	10
discovery and development	10
patent ductus arteriosus	10
for diagnostic tests	10
in the present	10
of biological products	10
from the united	10
as measured by	10
and the risk	10
prescribing information and	10
and patient information	10
of flexible endoscopes	10
marrow donor program	10
to understand the	10
efficacy of a	10
of the spr	10
patients who have	10
put in place	10
units were transfused	10
the differences in	10
have access to	10
recommendations for the	10
that is used	10
were performed by	10
and are not	10
would not be	10
and sterilization of	10
the fda issued	10
group a plasma	10
of the fd	10
more difficult to	10
contributed to the	10
a statistically significant	10
screen and identify	10
to continue to	10
and guidelines for	10
and to determine	10
and infectious diseases	10
for a total	10
studies are needed	10
are available for	10
of the high	10
serologic weak d	10
in this article	10
were obtained with	10
that they are	10
of units of	10
of ich guidelines	10
majority of these	10
director of the	10
as a new	10
blood donors and	10
in more than	10
the opportunity to	9
and marrow transplantation	9
information regarding the	9
ml of plasma	9
a concept paper	9
does not appear	9
antiviral activity of	9
and review of	9
samples obtained from	9
tandem mass spectrometry	9
they are used	9
by binding to	9
national marrow donor	9
to the increased	9
is clear that	9
data can be	9
will be a	9
and the european	9
an important tool	9
this is particularly	9
the late s	9
and has a	9
hematopoietic cell transplantation	9
did not differ	9
increased risk for	9
pharmaceutical supply chain	9
and the presence	9
blood donors for	9
the specificity of	9
study conducted by	9
under section b	9
leading cause of	9
to focus on	9
and stored at	9
been applied to	9
of some of	9
transferred to the	9
study aimed to	9
aim was to	9
clinic background case	9
as low as	9
will have a	9
it will be	9
infectious disease testing	9
is composed of	9
symptoms such as	9
blood system for	9
the impact on	9
performed using the	9
particularly in the	9
has been widely	9
in the manufacturing	9
but also the	9
immunoassay for the	9
a high level	9
university of pennsylvania	9
this is especially	9
of the risk	9
the range of	9
a safe and	9
mode of action	9
protection of public	9
time of the	9
a significant decrease	9
findings of a	9
the demand for	9
depend on the	9
and that the	9
public and private	9
associated with an	9
standard operating procedures	9
age and weight	9
have demonstrated that	9
to protect against	9
that should be	9
are used for	9
were assessed for	9
identity of the	9
the replication of	9
delayed hemolytic transfusion	9
blood donors in	9
a key role	9
concern about the	9
were selected for	9
review was performed	9
of the drugs	9
of the laboratory	9
and reduce the	9
of respiratory syncytial	9
has been suggested	9
organ transplant recipients	9
to analyze the	9
for whole blood	9
antibody screen and	9
appropriate use of	9
to the extent	9
data suggest that	9
in the use	9
ortho clinical diagnostics	9
these results suggest	9
among blood donors	9
on the safety	9
human clinical trials	9
the most effective	9
a need to	9
who have been	9
autoimmune hemolytic anemia	9
the mean number	9
is limited to	9
management of the	9
they are not	9
accordance with the	9
been made in	9
to aid in	9
on the type	9
took place in	9
approval of the	9
of less than	9
cytokine release syndrome	9
less than of	9
a retrospective analysis	9
indicated that the	9
was evaluated for	9
studies have been	9
pc in plasma	9
the detection and	9
of a patient	9
the problem of	9
number of donors	9
the pharmacokinetics of	9
safety of blood	9
a small number	9
entry into the	9
rather than a	9
derived from the	9
are expected to	9
high level of	9
is safe and	9
was added to	9
to optimize the	9
ct radiation dose	9
to be considered	9
medically important antibiotics	9
false positive results	9
absence of a	9
the generation of	9
children and adolescents	9
prenatal and postnatal	9
a framework for	9
in place to	9
resulted in an	9
acute respiratory distress	9
the registration of	9
are essential for	9
completion of the	9
rbc units were	9
a retrospective study	9
for this reason	9
as a treatment	9
total of patients	9
of viral infections	9
the influence of	9
for prevention of	9
samples were taken	9
performed a retrospective	9
blood loss and	9
the concept paper	9
we hypothesized that	9
of the original	9
the potential of	9
the office of	9
suggesting that the	9
the society for	9
into account the	9
relationship between the	9
into the host	9
to the drug	9
adverse drug reactions	9
was assessed by	9
on the same	9
and more than	9
the council of	9
the immucor neo	9
for the majority	9
position of the	9
of hepatitis c	9
referred to the	9
progress has been	9
the center for	9
the biological product	9
level of the	9
in developing countries	9
of the normal	9
the vaccine industry	9
at c for	9
entered into force	9
use in animal	9
in individuals with	9
of nucleic acid	9
effects of the	9
of standards and	9
and detection of	9
and administration of	9
a mean of	9
a pediatric patient	9
adopted by the	9
the college of	9
of congenital heart	9
is a need	9
for molecular pathology	9
were similar to	9
a high titer	9
patients who underwent	9
with the highest	9
access to testing	9
a single unit	9
to provide the	9
and risk of	9
for each patient	9
desorption ionization time	9
the costs of	9
crystal structure of	9
and biological products	9
was performed and	9
over the next	9
severity of the	9
all aspects of	9
aim is to	9
may be required	9
ct and mr	9
study published in	9
scope of the	9
have developed a	9
we have developed	9
is in the	9
in critically ill	9
if there is	9
risk factor for	9
by using the	9
a and anti	9
antiviral drugs were	9
report of a	9
in the pre	9
mean number of	9
that may not	9
suggests that the	9
have been established	9
response to therapy	9
for transmission of	9
studies have demonstrated	9
spread of the	9
which resulted in	9
the length of	9
can be observed	9
in the health	9
order to be	9
mri of the	9
the patient population	9
in the medical	9
white blood cell	9
positive and negative	9
patient with a	9
hcv and hiv	9
of the group	9
hospital transfusion service	9
the coordination of	9
for red blood	9
and the number	9
limited by the	9
by standard tube	9
is used as	9
for the registration	9
in the viral	9
by the national	9
nucleic acid test	9
although there is	9
produced by streptomyces	9
the pharmaceutical domain	9
high titer anti	9
at a dose	9
has not yet	9
of the university	9
in the current	9
of these donors	9
of the four	9
recommendations from the	9
the efficiency of	9
is likely to	9
differences between the	9
in a small	9
activities of the	9
large numbers of	9
von willebrand factor	9
is essential in	9
the united nations	9
septic transfusion reactions	9
at a rate	9
procedures for the	9
the host cells	9
of the rhd	9
for the same	9
role of the	9
in one study	9
respiratory distress syndrome	9
did not meet	9
potential inhibitors of	9
the emergency blood	9
was collected from	9
risk of transfusion	9
a pictorial essay	9
to implement a	9
donor screening and	9
in areas of	9
by inhibiting the	9
were analyzed using	9
statistical analysis was	9
to the same	9
of coronavirus disease	9
to identify and	9
and marrow transplant	9
patients with the	9
for a large	9
drug repurposing approach	9
of the distal	9
was performed at	9
in one patient	9
months to years	9
the list of	9
and at least	9
is that the	9
the central nervous	9
the release of	9
is related to	9
various types of	9
regional office for	9
old female with	9
in light of	9
present a case	9
be considered as	9
was measured using	9
were performed using	9
along with a	9
of the central	9
since its creation	9
in the identification	9
imaging findings and	9
the control group	9
could result in	9
of this article	9
review and meta	9
can be achieved	9
hb deferral rates	9
each member state	9
benign and malignant	9
performed by the	9
may be associated	9
for the most	9
result of the	9
technical and scientific	9
of the covid	9
has become a	9
to be in	9
us and eu	9
the national institutes	9
at a single	9
than of the	9
x l and	9
a significant difference	9
and did not	9
compared to controls	9
is recommended for	9
have been associated	9
detection of the	9
and also the	9
image quality and	9
the challenges of	9
the novel coronavirus	9
function of the	9
required for the	9
data needed to	9
of the two	9
b surface antigen	9
is to determine	9
that the product	9
critical for the	9
it was found	9
on the status	9
approximately of patients	9
hospital medical center	9
were analyzed by	9
be helpful in	9
an example of	9
a significant role	9
of the relevant	9
from donors with	9
the spinal cord	9
performed in a	9
rhd and rhce	9
to respond to	9
we report the	9
of the different	9
and approval of	9
sensitivity of the	9
relation to the	9
and duration of	9
the appearance of	9
soft tissue masses	9
significantly lower in	9
these studies are	9
in solid organ	8
to create an	8
would like to	8
to the right	8
in vitro diagnostic	8
dependent on the	8
of blood product	8
in the previous	8
retrospective study of	8
phase ii clinical	8
antibody screen was	8
community hospitals and	8
molecule antiviral drugs	8
stages of development	8
isolated from wbcs	8
center for drug	8
of this initiative	8
was conducted to	8
our blood bank	8
during the time	8
results were compared	8
event reporting system	8
it was noted	8
health and disease	8
similar to those	8
for apheresis platelets	8
lung disease in	8
of antibiotic use	8
drugs such as	8
the safety profile	8
the site of	8
fda approval for	8
what has been	8
to the ema	8
in the laboratory	8
an increased risk	8
on the ich	8
arterial tortuosity syndrome	8
to complete the	8
and is a	8
and there are	8
a month period	8
of medical countermeasures	8
amplicor mycobacterium tuberculosis	8
b of the	8
of safety and	8
routes of administration	8
human challenge studies	8
can only be	8
drug products from	8
published by the	8
may be at	8
blood components were	8
for which there	8
hospital for sick	8
representatives from the	8
for some of	8
drug administration fda	8
free movement of	8
case of the	8
results of these	8
c difficile spores	8
in animals and	8
this retrospective study	8
wide spectrum of	8
the two groups	8
for many years	8
of the tumor	8
none of these	8
a risk of	8
have resulted in	8
served as a	8
to allow the	8
results were obtained	8
as described in	8
of the recipient	8
of vascular anomalies	8
meeting of the	8
increasing number of	8
more than times	8
a collection of	8
was developed to	8
transfusion of blood	8
to the number	8
of each of	8
may contribute to	8
replication and transcription	8
has been demonstrated	8
the sensitivity and	8
reducing the risk	8
review of a	8
harmonization of the	8
is consistent with	8
of the association	8
human and animal	8
reagent red cells	8
regulatory authorities and	8
fda and ema	8
order to provide	8
of the great	8
of this presentation	8
to limit the	8
national cancer institute	8
and characterization of	8
to achieve this	8
in this chapter	8
of the agent	8
for viral replication	8
an attempt to	8
and computed tomography	8
hospital of philadelphia	8
that there are	8
in many countries	8
isrs were reported	8
the fda also	8
the survey was	8
this may be	8
entered into the	8
and those with	8
the healthcare system	8
the table below	8
the approval process	8
decreased from to	8
been able to	8
depends on the	8
of the program	8